E-LIB Suche - Ergebnisse für: Ying, Chaoqun

1

ESKAPE in China: epidemiology and characteristics of antibi..:

Luo, Qixia ; Lu, Ping ; Chen, Yunbo...
Emerging Microbes & Infections. 13 (2024) 1 - p. , 2024

Link: https://doi.org/10.1080/..

2

Clinical relevance, mechanisms, and evolution of polymyxin ..:

Luo, Qixia ; Xu, Linna ; Wang, Yuan...
Clinical Microbiology and Infection. 30 (2024) 4 - p. 507-514 , 2024

Link: https://doi.org/10.1016/..

3

Evaluation of Piperacillin/Sulbactam, Piperacillin/Tazobact..:

Wang, Xueting ; Xiong, Luying ; Yu, Wei...
Antibiotics. 12 (2023) 2 - p. 363 , 2023

Link: https://doi.org/10.3390/..

4

Cefepime, not Piperacillin/Tazobactam use, for empirical tr..:

Shi, Qingyi ; Huang, Chen ; Chen, Weizhuang...
European Journal of Pharmaceutical Sciences. 180 (2023) - p. 106334 , 2023

Link: https://doi.org/10.1016/..

5

Identification and Characterization of OXA-232-Producing Se..:

Chen, Tao ; Xu, Hongyun ; Chen, Yunbo...
Microbiology Spectrum. 11 (2023) 2 - p. , 2023

Link: https://doi.org/10.1128/..

6

Blood bacterial resistant investigation collaborative syste..:

Chen, Yunbo ; Ji, Jinru ; Ying, Chaoqun...
Antimicrobial Resistance & Infection Control. 11 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

7

Population genomics of emergingElizabethkingia anophelispat..:

Hu, Shaohua ; Xu, Hao ; Meng, Xiaohua...
Emerging Microbes & Infections. 11 (2022) 1 - p. 2590-2599 , 2022

Link: https://doi.org/10.1080/..

8

Genomic and Phenotypic Diversity of Carbapenemase-Producing..:

Zheng, Beiwen ; Xu, Hao ; Guo, Lihua...
Engineering. 12 (2022) - p. 90-100 , 2022

Link: https://doi.org/10.1016/..

9

In Vitro Activity Comparison of Ceftazidime–Avibactam and A..:

Yu, Wei ; Xiong, Luying ; Luo, Qixia...
Frontiers in Cellular and Infection Microbiology. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

10

Evaluation of Ceftazidime/Avibactam Administration in Enter..:

Dai, Yuanyuan ; Chang, Wenjiao ; Zhou, Xin...
Drug Design, Development and Therapy. 15 (2021) - p. 2899-2905 , 2021

Link: https://doi.org/10.2147/..

11

Antibacterial Activity and Optimal Treatment of Ceftazidime..:

Yu, Wei ; Chen, Yunbo ; Shen, Ping...
Frontiers in Pharmacology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

12

Analysis of Genetic Diversity and Antibiotic Options for Cl..:

Yu, Wei ; Huang, Yicheng ; Ying, Chaoqun...
Open Forum Infectious Diseases. 8 (2021) 6 - p. , 2021

Link: https://doi.org/10.1093/..

13

Optimal Empiric Polymyxin B Treatment of Patients Infected ..:

Wu, Xingbing ; Huang, Chen ; Wang, Hui...
Drug Design, Development and Therapy. 15 (2021) - p. 2593-2603 , 2021

Link: https://doi.org/10.2147/..

14

The Monte Carlo Simulation of Three Antimicrobials for Empi..:

Zou, Dongna ; Yao, Guangyue ; Shen, Chengwu...
Frontiers in Microbiology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

15

Risk factors and outcomes in non-transplant patients with e..:

Xiao, Tingting ; Yang, Kai ; Zhou, Yanzi...
Antimicrobial Resistance & Infection Control. 8 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..